1 – 20 of 48
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden – data from the Swedish Macula Register
(
- Contribution to journal › Article
-
Mark
Rationale and Design of VOYAGER : Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
(
- Contribution to journal › Article
- 2022
-
Mark
What about the fellow eye in treatment of neovascular age-related macular degeneration? Analysis of data from the Swedish macula register
(
- Contribution to journal › Article
-
Mark
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
(
- Contribution to journal › Article
-
Mark
Exploration of real-world outcomes and treatment patterns in patients treated with anti-vascular endothelial growth factors for neovascular age-related macular degeneration in Sweden
(
- Contribution to journal › Article
- 2021
-
Mark
A novel tool to assess the quality of RWE to guide the management of retinal disease
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)
(
- Contribution to journal › Article
-
Mark
Treatment algorithm with dexamethasone intravitreal implant in patients with diabetic macular edema
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION : An Expert Panel Consensus
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration : data from the INSIGHT study using the Swedish Macula Register
(
- Contribution to journal › Article
-
Mark
Association between diabetic eye disease and other complications of diabetes : Implications for care. A systematic review
(
- Contribution to journal › Scientific review
- 2017
-
Mark
No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same swedish county treated for wet age-related macular degeneration
(
- Contribution to journal › Article
-
Mark
Treatment for neovascular age-related macular degeneration in Sweden : outcomes at seven years in the Swedish Macula Register
(
- Contribution to journal › Article
- 2016
-
Mark
Reduced occurrence of severe visual impairment after introduction of anti-Vascular Endothelial Growth Factor in wet age-related macular degeneration – a population- and register-based study from northern Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema.
(
- Contribution to journal › Article
-
Mark
The prognosis of diabetic retinopathy in patients with type 2 diabetes since 1996-1998: the Skaraborg Diabetes Register
(
- Contribution to journal › Article
- 2014
-
Mark
Diabetes- ögonsjukvård i förändring : ett stickprovs betydelse.
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2013
-
Mark
Three-year follow-up of visual outcome and quality of life in patients with age-related macular degeneration
(
- Contribution to journal › Article
-
Mark
Intravitreal Injection of Triamcinolone Acetonide into Healthy Rabbit Eyes Alters Retinal Function and Morphology
(
- Contribution to journal › Article
-
Mark
Macular dysfunction in drusen maculopathy assessed with multifocal electroretinogram and optical coherence tomography.
(
- Contribution to journal › Article